+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Vitamin IV Therapy Product Market by Product (Medicated, Non-medicated), Type of IV Therapy (Anti-Aging IV, Detoxification IV, Hydration Therapy), Formulation Type, End-User, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • March 2025
  • Region: Global
  • 360iResearch™
  • ID: 6055319
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Vitamin IV Therapy Product Market grew from USD 3.12 billion in 2024 to USD 3.35 billion in 2025. It is expected to continue growing at a CAGR of 7.71%, reaching USD 4.88 billion by 2030.

Vitamin IV Therapy has emerged as a dynamic solution in the wellness and healthcare sectors, reflecting both a paradigm shift in consumer priorities and an innovative approach to nutritional supplementation. In recent years, this market has transcended its initial niche applications to become a key component in broader health management strategies. The rapid evolution of this industry is largely due to an increasing global demand for personalized wellness solutions, where intravenous nutrient delivery is being recognized not only for its immediate benefits but also for its potential in long-term health optimization. This report provides an insightful overview of current market trends, underlying transformative shifts, and a deep dive into the segmentation that is driving the industry forward. By exploring fundamental market drivers, evolving consumer behaviors, and innovative technological integrations, stakeholders can glean strategic insights necessary to navigate this ever-changing terrain. The discussion is structured to deliver both a macro and micro perspective on the Vitamin IV Therapy industry, focusing on market growth, investment opportunities, and future challenges.

Transformative Shifts Reshaping the Vitamin IV Therapy Landscape

Over recent years, the Vitamin IV Therapy market has experienced transformative shifts propelled by technological advancements, regulatory evolutions, and changing consumer lifestyles. This sector is no longer defined solely by its therapeutic applications; instead, it has evolved into a multifaceted industry that integrates broader wellness trends, digital health advancements, and emerging consumer demands. Market participants now benefit from enhanced monitoring and diagnostic tools that allow for more precise formulations and tailored treatments. The infusion techniques have been meticulously refined, ensuring safety and efficacy while also addressing a spectrum of consumer needs - from preventive wellness to acute therapeutic interventions. Additionally, progressive research and scientific validation have bolstered confidence among medical professionals, which in turn has increased the adoption of IV therapies across diverse settings. With improvements in formulation technologies and the integration of digital tracking systems, industry stakeholders are well positioned to navigate new market dynamics. The evolving regulatory landscape, although challenging, has also spurred innovation by encouraging safe-adoption practices and strategic partnerships within the healthcare and wellness communities.

In-Depth Segmentation Analysis of the Vitamin IV Therapy Market

A nuanced understanding of the market’s segmentation reveals a spectrum of factors that are crucial in deciphering consumer behavior and market potential. The product segmentation divides the market into medicated and non-medicated solutions, each offering distinct approaches to health and wellness. Insights are further enriched by the segmentation based on the type of IV therapy, which spans anti-aging IV, detoxification IV, hydration therapy, and immune boosting IV. This refined categorization helps in understanding the varied consumer priorities that include longevity, toxin removal, optimal hydration, and immune system support. An additional layer of segmentation based on formulation type differentiates between multi-ingredient formulations and single-ingredient formulations, a factor that underscores both complexity and customization capabilities in therapy protocols. Moreover, end-user segmentation breaks down the market into diverse channels such as athletic performance centers, homecare settings, hospitals and clinics, and wellness as well as aesthetic centers. Finally, the application-based segmentation offers insight into specific areas of use including athletic recovery and performance, chronic disease management, hangover relief and hydration therapy, immune system boosting, mental health and cognitive function, weight management, and overall wellness and rejuvenation. These segmentation insights provide industry players with an in-depth, layered understanding that is critical for targeted marketing, product development, and strategic investment decisions.

Based on Product, market is studied across Medicated and Non-medicated.

Based on Type of IV Therapy, market is studied across Anti-Aging IV, Detoxification IV, Hydration Therapy, and Immune Boosting IV.

Based on Formulation Type, market is studied across Multi-Ingredient Formulations and Single-Ingredient Formulations.

Based on End-User, market is studied across Athletic Performance Centers, Homecare Settings, Hospitals & Clinics, and Wellness & Aesthetic Centers.

Based on Application, market is studied across Athletic Recovery & Performance, Chronic Disease Management, Hangover Relief & Hydration Therapy, Immune System Boosting, Mental Health & Cognitive Function, Weight Management, and Wellness & Rejuvenation.

Regional Dynamics in the Vitamin IV Therapy Market

Geographical analysis of the Vitamin IV Therapy market manifests diverse trends and regional particularities that influence both market demand and competitive strategies. In the Americas, a robust consumer culture blended with high healthcare expenditure and an inherent inclination towards wellness solutions fosters a lively market environment. This region is characterized by a well-established infrastructure, supportive regulatory policies, and an increasing number of wellness centers integrating IV therapy into their portfolios. In contrast, the Europe, Middle East & Africa region shows a growing enthusiasm driven by the reinterpretation of wellness paradigms and innovative health practices. Here, a combination of advanced healthcare facilities and a cultural inclination towards alternative therapies creates an attractive landscape for vitamin-based treatments. The Asia-Pacific region, with its rapid urbanization and a burgeoning middle class, represents a particularly exciting opportunity. An evolving awareness of the benefits of Vitamin IV Therapy, coupled with increasing healthcare investments and a rising demand for preventive care, positions this region as a new frontier for market expansion. Each of these regions exhibits unique growth drivers, varying degrees of market maturity, and dynamic consumer preferences that require a tailored approach to capture emerging opportunities.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Competitive Landscape and Key Players in the Vitamin IV Therapy Industry

The competitive arena in the Vitamin IV Therapy market is marked by a blend of large global healthcare conglomerates and emerging specialized providers. Prominent companies such as Amanta Healthcare Limited and B. Braun SE continue to leverage their extensive portfolios and global distribution networks to assert a dominant presence in the industry. Baxter International Inc., Boost IV, Core IV Therapy, LLC, and Cryojuvenate UK Ltd reflect both innovation and consistent performance by offering niche services that respond to shifting consumer demands. Other influential players including DaVita Inc., Drip Hydration, Hydrate IV Bar Holdings, LLC, and HYDRATION ROOM have carved out significant market share by continuously enhancing service delivery and innovative treatment techniques. IV League, JUST LIVV, INC, and JW Life Science Corporation contribute through dynamic product offerings, while Mobile IV Medics, Inc., NexGen Health, Otsuka Pharmaceutical Co., Ltd., PrimeIV Hydration & Wellness, and Restore Franchising, LLC focus on strategic partnerships and integrated health solutions. REVIV Global Ltd., Revival IV Lounge, The I.V. Doc, The Wellness Co., Unilever PLC, Vida-Flo USA, and Vitamin IV Therapy, Inc. also play crucial roles by driving market diversification, promoting advanced technological innovations, and setting high standards for customer service. Together, these companies not only influence pricing structures and product evolution but also set the pace for research and development initiatives across the broader market landscape.

The report delves into recent significant developments in the Vitamin IV Therapy Product Market, highlighting leading vendors and their innovative profiles. These include Amanta Healthcare Limited, B. Braun SE, Baxter International Inc., Boost IV, Core IV Therapy, LLC, Cryojuvenate UK Ltd, DaVita Inc., Drip Hydration, Hydrate IV Bar Holdings, LLC, HYDRATION ROOM, IV League, JUST LIVV, INC, JW Life Science Corporation, Mobile IV Medics, Inc., NexGen Health, Otsuka Pharmaceutical Co., Ltd., PrimeIV Hydration & Wellness, Restore Franchising, LLC., REVIV Global Ltd., Revival IV Lounge, The I.V. Doc, The Wellness Co., Unilever PLC, Vida-Flo USA, and Vitamin IV Therapy, Inc..

Actionable Recommendations to Drive Market Success

For industry leaders looking to capitalize on the evolving Vitamin IV Therapy market, several actionable recommendations are paramount. First, continuous investment in research and development should be prioritized to keep pace with advancements in formulation and technology. Innovating both in multi-ingredient and single-ingredient formulations will foster a greater degree of personalization and efficacy, thus catering to a diverse audience. Second, establishing strategic partnerships with regional healthcare organizations and wellness centers can provide deeper market penetration and a competitive edge. Customizing product offerings based on geographic insights and consumer behavior trends is essential for staying ahead in a fragmented market. Third, companies should enhance consumer engagement by integrating digital health platforms for better tracking of therapeutic outcomes. This integration not only reinforces patient trust but also augments data collection for ongoing refinements in service delivery. Additionally, diversifying service delivery channels, whether through athletic performance centers, homecare settings, or hospital collaborations, broadens the customer base and increases brand visibility. Moreover, embracing comprehensive marketing and educational campaigns to elucidate the benefits of IV therapies across various applications - from mental health and cognitive function to athletic recovery and chronic disease management - will drive both demand and market maturity. Finally, a focus on compliance and adaptive regulatory strategies is crucial for mitigating operational risks while paving the way for sustainable, long-term growth.

Strategic Outlook for Vitamin IV Therapy

In conclusion, the Vitamin IV Therapy market is at an inflection point, propelled by innovative convergence of product diversity, technological advancements, and shifting consumer preferences. This comprehensive analysis highlights the importance of understanding segmentation nuances, recognizing regional opportunities, and keeping a close eye on the competitive dynamics that define industry leadership. The integration of personalized treatments, streamlined digital health solutions, and strategic alliances serves as the bedrock for future growth in this evolving landscape. As the market continues to mature and redefine wellness paradigms, stakeholders are encouraged to adopt strategies that leverage both micro and macro trends. Embracing agile and data-informed decision-making will be central to unlocking further potential in this transformative industry. Ultimately, the combination of innovation, customer-centric approaches, and robust market analytics will empower leaders to navigate challenges and capitalize on emerging opportunities.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in chronic diseases and lifestyle disorders globally
5.1.1.2. Growing preference for minimally invasive treatments over oral supplements and medications
5.1.1.3. Rapid expansion in wellness tourism with IV therapy offerings at upscale spas and wellness centers
5.1.2. Restraints
5.1.2.1. Lack of sufficient clinical evidence for long-term efficacy
5.1.3. Opportunities
5.1.3.1. Expanding presence in medical tourism by offering vitamin IV therapy packages for international clients
5.1.3.2. Developing a line of vitamin IV therapies that support mental health and cognitive function improvements
5.1.4. Challenges
5.1.4.1. Complexities of consumer perception and misconceptions about vitamin IV therapy
5.2. Market Segmentation Analysis
5.2.1. Type of IV Therapy: Increasing preference for detoxification IV therapy for improving metabolic balance
5.2.2. Application: Expanding application of vitamin IV therapy in chronic disease management
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Vitamin IV Therapy Product Market, by Product
6.1. Introduction
6.2. Medicated
6.3. Non-medicated
7. Vitamin IV Therapy Product Market, by Type of IV Therapy
7.1. Introduction
7.2. Anti-Aging IV
7.3. Detoxification IV
7.4. Hydration Therapy
7.5. Immune Boosting IV
8. Vitamin IV Therapy Product Market, by Formulation Type
8.1. Introduction
8.2. Multi-Ingredient Formulations
8.3. Single-Ingredient Formulations
9. Vitamin IV Therapy Product Market, by End-User
9.1. Introduction
9.2. Athletic Performance Centers
9.3. Homecare Settings
9.4. Hospitals & Clinics
9.5. Wellness & Aesthetic Centers
10. Vitamin IV Therapy Product Market, by Application
10.1. Introduction
10.2. Athletic Recovery & Performance
10.3. Chronic Disease Management
10.4. Hangover Relief & Hydration Therapy
10.5. Immune System Boosting
10.6. Mental Health & Cognitive Function
10.7. Weight Management
10.8. Wellness & Rejuvenation
11. Americas Vitamin IV Therapy Product Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Vitamin IV Therapy Product Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Vitamin IV Therapy Product Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Scenario Analysis
14.3.1. Hydreight Technologies partners with The DRIPBaR to launch DRIPBaR Direct as a nationwide direct-to-consumer platform for at-home IV therapy
14.3.2. Cardone Ventures’ 10X Health and REVIV Global launch a science-driven, genetically tailored IV therapy system to enhance precision nutrition in the UK
14.3.3. Hydralive therapy secures USD 2.2 million growth funding to accelerate customized IV therapy and wellness services franchising
14.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. VITAMIN IV THERAPY PRODUCT MARKET MULTI-CURRENCY
FIGURE 2. VITAMIN IV THERAPY PRODUCT MARKET MULTI-LANGUAGE
FIGURE 3. VITAMIN IV THERAPY PRODUCT MARKET RESEARCH PROCESS
FIGURE 4. VITAMIN IV THERAPY PRODUCT MARKET SIZE, 2024 VS 2030
FIGURE 5. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 6. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 9. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2024 VS 2030 (%)
FIGURE 11. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2030 (%)
FIGURE 13. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 15. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 17. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 18. AMERICAS VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 19. AMERICAS VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 20. UNITED STATES VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 21. UNITED STATES VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 22. ASIA-PACIFIC VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 23. ASIA-PACIFIC VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 26. VITAMIN IV THERAPY PRODUCT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 27. VITAMIN IV THERAPY PRODUCT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. VITAMIN IV THERAPY PRODUCT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. VITAMIN IV THERAPY PRODUCT MARKET DYNAMICS
TABLE 7. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY MEDICATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY NON-MEDICATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY ANTI-AGING IV, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY DETOXIFICATION IV, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY HYDRATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY IMMUNE BOOSTING IV, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY MULTI-INGREDIENT FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY SINGLE-INGREDIENT FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY ATHLETIC PERFORMANCE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY WELLNESS & AESTHETIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY ATHLETIC RECOVERY & PERFORMANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY HANGOVER RELIEF & HYDRATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY IMMUNE SYSTEM BOOSTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY MENTAL HEALTH & COGNITIVE FUNCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY WEIGHT MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY WELLNESS & REJUVENATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. CANADA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. CANADA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 49. CANADA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 50. CANADA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. CANADA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. MEXICO VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. MEXICO VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 54. MEXICO VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 55. MEXICO VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. MEXICO VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. AUSTRALIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 71. AUSTRALIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 72. AUSTRALIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. AUSTRALIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. CHINA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. CHINA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 76. CHINA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 77. CHINA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. CHINA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. INDIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. INDIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 81. INDIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 82. INDIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. INDIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. INDONESIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 86. INDONESIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 87. INDONESIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. INDONESIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. JAPAN VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. JAPAN VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 91. JAPAN VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 92. JAPAN VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. JAPAN VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. MALAYSIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 96. MALAYSIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 97. MALAYSIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. MALAYSIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. PHILIPPINES VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 101. PHILIPPINES VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 102. PHILIPPINES VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. PHILIPPINES VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 105. SINGAPORE VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 106. SINGAPORE VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 107. SINGAPORE VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. SINGAPORE VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. SOUTH KOREA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 111. SOUTH KOREA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 112. SOUTH KOREA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 113. SOUTH KOREA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. TAIWAN VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 116. TAIWAN VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 117. TAIWAN VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. TAIWAN VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. THAILAND VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. THAILAND VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 121. THAILAND VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 122. THAILAND VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. THAILAND VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. VIETNAM VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 126. VIETNAM VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 127. VIETNAM VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. VIETNAM VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 135. DENMARK VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 136. DENMARK VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 137. DENMARK VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 138. DENMARK VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. DENMARK VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. EGYPT VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. EGYPT VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 142. EGYPT VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 143. EGYPT VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. EGYPT VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. FINLAND VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 146. FINLAND VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 147. FINLAND VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 148. FINLAND VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 149. FINLAND VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. FRANCE VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. FRANCE VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 152. FRANCE VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 153. FRANCE VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 154. FRANCE VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. GERMANY VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 156. GERMANY VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 157. GERMANY VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 158. GERMANY VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 159. GERMANY VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 161. ISRAEL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 162. ISRAEL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 163. ISRAEL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 164. ISRAEL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. ITALY VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 166. ITALY VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 167. ITALY VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 168. ITALY VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 169. ITALY VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 171. NETHERLANDS VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 172. NETHERLANDS VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 173. NETHERLANDS VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 174. NETHERLANDS VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 176. NIGERIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 177. NIGERIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 178. NIGERIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 179. NIGERIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. NORWAY VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 181. NORWAY VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 182. NORWAY VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 183. NORWAY VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 184. NORWAY VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. POLAND VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 186. POLAND VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 187. POLAND VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 188. POLAND VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 189. POLAND VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. QATAR VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 191. QATAR VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 192. QATAR VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 193. QATAR VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 194. QATAR VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 199. RUSSIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 204. SAUDI ARABIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 208. SOUTH AFRICA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. SPAIN VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 211. SPAIN VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 212. SPAIN VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 213. SPAIN VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 214. SPAIN VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 216. SWEDEN VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 217. SWEDEN VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 218. SWEDEN VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 219. SWEDEN VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 221. SWITZERLAND VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 222. SWITZERLAND VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 223. SWITZERLAND VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 224. SWITZERLAND VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. TURKEY VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 226. TURKEY VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 227. TURKEY VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 228. TURKEY VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 229. TURKEY VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 238. UNITED KINGDOM VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. VITAMIN IV THERAPY PRODUCT MARKET SHARE, BY KEY PLAYER, 2024
TABLE 241. VITAMIN IV THERAPY PRODUCT MARKET, FPNV POSITIONING MATRIX, 2024

Companies Mentioned

  • Amanta Healthcare Limited
  • B. Braun SE
  • Baxter International Inc.
  • Boost IV
  • Core IV Therapy, LLC
  • Cryojuvenate UK Ltd
  • DaVita Inc.
  • Drip Hydration
  • Hydrate IV Bar Holdings, LLC
  • HYDRATION ROOM
  • IV League
  • JUST LIVV, INC
  • JW Life Science Corporation
  • Mobile IV Medics, Inc.
  • NexGen Health
  • Otsuka Pharmaceutical Co., Ltd.
  • PrimeIV Hydration & Wellness
  • Restore Franchising, LLC.
  • REVIV Global Ltd.
  • Revival IV Lounge
  • The I.V. Doc
  • The Wellness Co.
  • Unilever PLC
  • Vida-Flo USA
  • Vitamin IV Therapy, Inc.

Methodology

Loading
LOADING...

Table Information